Skip to main content

Advertisement

SpringerLink
Log in

Response to a letter to the editor related to Graefe’s Arch Clin Exp Ophthalmol. 2023 April; 261(4):951–957. “Blood neutrophil-to-lymphocyte ratio as a risk factor in the treatment of retinopathy of prematurity”

  • Letter to the Editor (by invitation)
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahn YJ, Hong KE, Yum HR, Lee JH, Kim KS, Youn YA, Park SH (2017) Characteristic clinical features associated with aggressive posterior retinopathy of prematurity. Eye (Lond) 31:924–930. https://doi.org/10.1038/eye.2017.18

    Article  CAS  PubMed  Google Scholar 

  2. Mitra S, Aune D, Speer CP, Saugstad OD (2014) Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology 105:189–199. https://doi.org/10.1159/000357556

    Article  PubMed  Google Scholar 

  3. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD (1998) Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 116:601–605. https://doi.org/10.1001/archopht.116.5.601

    Article  CAS  PubMed  Google Scholar 

  4. Fundora JB, Binenbaum G, Tomlinson L, Yu Y, Ying GS, Maheshwari A, Donohue P (2021) Association of surgical necrotizing enterocolitis and its timing with retinopathy of prematurity. Am J Perinatol. https://doi.org/10.1055/s-0041-1733785

  5. Lee J, Dammann O (2012) Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med 17:26–29. https://doi.org/10.1016/j.siny.2011.08.007

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ellen Knapp, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan

    Shumpei Obata & Masahito Ohji

  2. Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan

    Takahide Yanagi

Authors
  1. Shumpei Obata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takahide Yanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahito Ohji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shumpei Obata.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obata, S., Yanagi, T. & Ohji, M. Response to a letter to the editor related to Graefe’s Arch Clin Exp Ophthalmol. 2023 April; 261(4):951–957. “Blood neutrophil-to-lymphocyte ratio as a risk factor in the treatment of retinopathy of prematurity”. Graefes Arch Clin Exp Ophthalmol 261, 2723–2724 (2023). https://doi.org/10.1007/s00417-023-06125-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-023-06125-x

Search

Navigation